Inagene Logo.jpg
September’s International Pain Awareness Month marks critical moment to leverage more effective methods of treating chronic pain
26 août 2021 06h00 HE | Inagene Diagnostics Inc.
TORONTO, Aug. 26, 2021 (GLOBE NEWSWIRE) -- September marks Canada’s most important International Pain Awareness Month yet. The stressors brought on by the COVID-19 pandemic have manifested as new...
InvestorBrandNetwork Announces The Dealmaker Show Interview with Tryp Therapeutics Inc. CEO Greg McKee
03 août 2021 08h00 HE | InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
FDA Clears Sorrento Phase 2 Trial Of Non-Opioid Product Candidate Resiniferatoxin (RTX) For Treatment of the Knee Pain in Osteoarthritis (OA) Patients
06 juil. 2021 14h34 HE | Sorrento Therapeutics, Inc.
Phase 2 trial of RTX for OA pain to proceed following FDA clearance.Phase 1b data demonstrated RTX safety for a single intra-articular administration without dose limiting toxicity (DLT) at any doses...
RYAH logo.jpg
RYAH Group, Inc Publishes Report on Medical Cannabis Use for Pain
10 juin 2021 08h00 HE | Potbotics, Inc. o/a RYAH
TORONTO, June 10, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company”) is pleased to announce that its wholly owned subsidiary, RYAH Medtech Inc. ("RYAH...
Trevena, Inc. to Participate at the Sachs Associates 4th Annual Neuroscience Innovation Forum
29 avr. 2021 07h00 HE | Trevena Inc.
CHESTERBROOK, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central...
HC2 Logo.jpg
HC2 Holdings Portfolio Company R2 Technologies Receives Final Tranche of $30 Million Investment
03 févr. 2021 08h45 HE | HC2 Holdings, Inc.
NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2” or “the Company”) (NYSE: HCHC) today announced that R2 Technologies Inc. ("R2"), founded by HC2’s portfolio company Pansend Life...
Sorrento Releases Positive Results of Phase 1B Trial of Resiniferatoxin (RTX) In Reduction of OsteoArthritis (OA) Knee Pain
28 sept. 2020 09h00 HE | Sorrento Therapeutics, Inc.
Phase 1b safety data at 6 month post-administration and Day 84 efficacy data available for all patients enrolled.No dose limiting toxicities at any of the doses tested (up to 30 ug) at 6 months...
AMR Logo.png
Pain Management Devices Market to Reach $6.77 Billion by 2026 at 6.7% CAGR
26 août 2020 10h15 HE | Allied Market Research
Portland, OR, Aug. 26, 2020 (GLOBE NEWSWIRE) -- According to the report, the global pain management devices industry accounted for $4.01 billion in 2018, and is anticipated to reach $6.77 billion by...
Berg Nutrition Brings a Unique Form of Pure Capsaicin Called aXivite to U.S. Marketplace
28 juil. 2020 10h02 HE | Berg Nutrition
ANN ARBOR, Mich., July 28, 2020 (GLOBE NEWSWIRE) -- Berg Nutrition has been named the exclusive U.S. distributer of the branded ingredient, aXivite phenylcapsaicin, a synthetic, innovative form of...
Biotricity Launches Innovative Pain Management Product with NeuPath Health
10 mars 2020 08h00 HE | biotricity
REDWOOD CITY, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has launched its...